Precision BioSciences (DTIL) Balance Sheet: Assets & Liabilities

Precision BioSciences (DTIL) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Precision BioSciences reported total assets of $154.42M and total liabilities of $62.17M. Shareholders' equity was $92.25M, up 63.6% from $56.39M a year earlier. Total debt stood at $23.91M against $115.58M in cash and short-term investments, a net cash position of $91.67M. That puts debt-to-equity at 0.26, compared with 0.42 a year earlier.

Precision BioSciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Precision BioSciences, Inc. (DTIL) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	110.82	85.90	116.68	189.58	143.66	89.80	180.89	103.19	62.80
Short-Term Investments	4.76	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	115.59	86.31	116.68	189.58	143.66	89.80	180.89	103.19	62.80
Accounts Receivable	0.00	0.23	0.90	0.72	0.49	10.00	0.97	0.52	0.02
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.16	6.98	6.88	1.23	17.60	5.77	11.82	11.96	1.51
Total Current Assets	118.74	94.99	136.36	199.11	161.75	105.56	193.67	115.68	64.33
Non-Current Assets
Property, Plant & Equipment (Net)	7.23	10.18	8.26	13.78	29.33	41.50	39.57	21.15	8.14
Long-Term Investments	0.74	7.81	8.20	2.17	6.84	0.00	0.00	0.00	0.00
Intangible Assets	1.17	0.62	0.40	0.73	2.05	1.37	1.43	1.47	0.09
Other Non-Current Assets	26.54	22.79	6.56	12.57	11.52	1.72	0.56	0.31	0.12
Total Non-Current Assets	35.68	41.40	23.42	39.06	49.74	44.59	41.56	22.93	8.35
Total Assets	154.42	136.39	159.78	238.17	211.50	150.16	235.23	138.60	72.68
Current Liabilities
Accounts Payable	0.30	1.31	2.97	0.65	1.14	0.79	2.04	2.22	1.81
Short-Term Debt	1.51	1.32	22.41	1.68	1.82	1.93	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	-	22.41	-	-	-	-	-	-
Accrued Liabilities	6.46	7.20	6.54	1.83	4.03	9.01	-	-	-
Deferred Revenue	0.00	2.96	12.04	46.19	21.24	30.24	16.49	8.44	5.82
Other Current Liabilities	0.65	2.19	4.90	4.21	11.77	9.87	8.41	3.42	1.57
Total Current Liabilities	8.91	14.98	49.99	59.66	35.98	42.83	26.93	14.08	9.20
Non-Current Liabilities
Long-Term Debt	22.40	22.32	7.72	22.22	7.29	8.59	0.00	0.00	0.00
Other Non-Current Liabilities	25.95	36.29	83.21	0.20	0.04	0.39	4.09	1.76	1.25
Total Non-Current Liabilities	53.26	65.02	90.93	118.07	84.35	62.90	69.99	84.57	89.85
Total Liabilities	62.17	80.00	140.92	177.74	120.33	105.73	96.92	98.64	99.05
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-528.19	-482.46	-489.63	-428.31	-316.68	-286.07	-177.07	-85.19	-39.11
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-5.48	-3.19
Treasury Stock	0.95	0.95	0.95	0.95	0.95	-	-	-	-
Additional Paid-in Capital	621.39	539.81	509.44	489.70	407.84	330.50	315.38	125.14	15.93
Shares Outstanding	24.09	8.20	4.16	3.70	2.03	-	-	-	-
Total Stockholders' Equity	92.25	56.39	18.86	60.43	91.17	44.43	138.31	39.96	-26.37
Total Liabilities & Equity	154.42	136.39	159.78	238.17	211.50	150.16	235.23	138.60	72.68

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Precision BioSciences Balance Sheet

How much debt does Precision BioSciences have?

Precision BioSciences had total debt of $23.91M as of Dec 31, 2025, against $115.58M in cash and short-term investments. Its debt-to-equity ratio was 0.26. Total debt was $23.64M a year earlier.

What are Precision BioSciences's total assets?

Precision BioSciences reported total assets of $154.42M as of Dec 31, 2025, up 13.2% from $136.39M a year earlier. Total liabilities were $62.17M.

What is Precision BioSciences's shareholders' equity?

Precision BioSciences's shareholders' equity was $92.25M as of Dec 31, 2025, or about $3.83 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition